A share price of Revolution Medicines Inc [RVMD] is currently trading at $47.82, up 2.68%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The RVMD shares have gain 4.27% over the last week, with a monthly amount glided 16.81%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Truist started tracking the stock with Buy rating on September 05, 2025, and set its price target to $99. On August 19, 2025, Piper Sandler initiated with a Overweight rating and assigned a price target of $75 on the stock. Wells Fargo started tracking the stock assigning a Overweight rating and suggested a price target of $67 on August 15, 2025. Goldman initiated its recommendation with a Buy and recommended $65 as its price target on July 15, 2025. Needham reiterated a Buy rating for this stock on July 16, 2024, and upped its price target to $62. In a note dated July 12, 2024, Barclays initiated an Overweight rating and provided a target price of $52 on this stock.
Revolution Medicines Inc experienced fluctuations in its stock price throughout the past year between $29.17 and $62.40. Currently, Wall Street analysts expect the stock to reach $82 within the next 12 months. Revolution Medicines Inc [NASDAQ: RVMD] shares were valued at $47.82 at the most recent close of the market. An investor can expect a potential return of 71.48% based on the average RVMD price forecast.
Analyzing the RVMD fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is -0.42 and Total Capital is -0.4. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 46.15 points at the first support level, and at 44.48 for the second support level. However, for the 1st resistance point, the stock is sitting at 49.49, and for the 2nd resistance point, it is at 51.17.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Revolution Medicines Inc [NASDAQ:RVMD] is 11.79. Further, the Quick Ratio stands at 11.79, while the Cash Ratio is 2.18.
Transactions by insiders
Recent insider trading involved Cislini Jeff, General Counsel, that happened on Sep 24 ’25 when 1799.0 shares were sold. Officer, JEFFREY TODD CISLINI completed a deal on Sep 24 ’25 to buy 1799.0 shares. Meanwhile, Chief Medical Officer Wei Lin sold 2160.0 shares on Sep 16 ’25.
